EXACT Therapeutics minutes from Annual General Meeting June 12, 2026

OSLO, 12 June 2026: EXACT Therapeutics AS (“EXACT-Tx”, “the Company” Euronext Growth: EXTX) held its Annual General Meeting on June 12, 2026 at 10:30 CEST.

All proposed resolutions were approved.

Please find enclosed the minutes of the meeting including appendices. The minutes will also be available on the company website: www.exact-tx.com

For more information, please contact:

Per Walday, CEO EXACT Therapeutics Email per.walday@exact-tx.com

John M. Edminson, CFO EXACT Therapeutics Email: john.edminson@exact-tx.com

About EXACT Therapeutics: EXACT Therapeutics is a clinical-stage precision medicine company utilizing the power of ultrasound to activate the proprietary drug PS101 and enhance the clinical benefit of oncology therapies. PS101 has a unique mode of action and may be combined with a wide range of therapeutic agents within oncology and across a multitude of other indications, including brain diseases. EXACT Therapeutics’ shares are traded on Euronext Growth Oslo (EXTX). Further information may be found here: www.exact-tx.com